收费全文 | 503篇 |
免费 | 16篇 |
国内免费 | 10篇 |
耳鼻咽喉 | 13篇 |
儿科学 | 49篇 |
妇产科学 | 14篇 |
基础医学 | 21篇 |
口腔科学 | 8篇 |
临床医学 | 46篇 |
内科学 | 116篇 |
皮肤病学 | 19篇 |
神经病学 | 76篇 |
特种医学 | 8篇 |
外科学 | 83篇 |
综合类 | 7篇 |
预防医学 | 21篇 |
眼科学 | 20篇 |
药学 | 15篇 |
肿瘤学 | 13篇 |
2023年 | 2篇 |
2022年 | 11篇 |
2021年 | 13篇 |
2020年 | 9篇 |
2019年 | 7篇 |
2018年 | 5篇 |
2017年 | 11篇 |
2016年 | 13篇 |
2015年 | 12篇 |
2014年 | 15篇 |
2013年 | 26篇 |
2012年 | 33篇 |
2011年 | 32篇 |
2010年 | 16篇 |
2009年 | 11篇 |
2008年 | 41篇 |
2007年 | 44篇 |
2006年 | 50篇 |
2005年 | 49篇 |
2004年 | 27篇 |
2003年 | 26篇 |
2002年 | 30篇 |
2001年 | 7篇 |
2000年 | 4篇 |
1999年 | 2篇 |
1998年 | 1篇 |
1997年 | 4篇 |
1996年 | 3篇 |
1995年 | 1篇 |
1994年 | 3篇 |
1993年 | 3篇 |
1992年 | 2篇 |
1989年 | 1篇 |
1988年 | 2篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 1篇 |
1982年 | 3篇 |
1980年 | 1篇 |
1978年 | 3篇 |
1976年 | 1篇 |
1974年 | 1篇 |
1955年 | 1篇 |
![点击此处可从《Psychiatry and clinical neurosciences》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Objectives
Atypical antipsychotics (AAPs) have been reported to cause metabolic dysregulation that can cause AAPs-related weight gain. The purpose of this study was to assess triglyceride, cholesterol, and weight changes among risperidone-treated children and youths.Methods
Eighty-one subjects treated with risperidone for any psychiatric disturbances were included in the study. Fasting total low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), total cholesterol (TC), and triglyceride (TG) levels were measured at the baseline and at the sixth month of treatment.Results
TG, TC and LDL-C levels increased over time and reached statistical significance but there has been no change in HDL-C levels. Seven subjects (8.64%) crossed the threshold into clinically significant hypertriglyceridemia, four subjects (4.94%) crossed the threshold into clinically significant hypercholesterolemia, defined as going over the 95th percentile of published age normed plasma TG and TC levels, respectively. There was a positive correlation between TG and TC elevations and weight gain. There was no significant association with age, gender, diagnoses, risperidone dose and changes of serum TG, TC or LDL-C levels.Conclusion
The present study identified significant associations between lipid dysregulation and risperidone treatment. Since there is little research available on long-term lipid profile follow-up with atypical antipsychotics treatment in children and youths, controlled studies in larger samples should be carried out to reveal the relationship between risperidone use and plasma lipid parameters in the pediatric population. 相似文献Objectives
This cross-sectional study was conducted with the aim of determining the quality of sexual life and related factors in women with gynaecological cancers.Methods
The study was conducted in the gynaecological oncology clinic of a state hospital. Women who were diagnosed with gynaecological cancers constituted the study population. Eighty married women who were diagnosed with cancer and who agreed to participate were included in the study. Data were collected by a personal data form, the Sexual Quality of Life (SQOL) Questionnaire-Female and the Multidimensional Scale of Perceived Social Support (MSPSS).Results
The mean age of the women was 52.16 (SD 10.04). Of the patients, 61.3% had ovarian cancer, 22.5% endometrial cancer, and 13.8% cervical cancer and 56.3% had been diagnosed with cancer during the previous year. Sixty percent of the women were receiving cancer therapy. The mean score of MSPSS was 67.60 (SD 14.03), and SQOL was 52.50 (SD 22.87). Although there was no significant difference between mean SQOL according to individual and disease characteristics, a positive statistically significant relationship was detected between total and subdimension (family, friend and significant other) scores of MSPSS (p?0.05).Conclusions
According to the results obtained from the study, it can be stated that the sexual quality of life of women with gynaecological cancers is moderate and social support, especially support from a significant person, may affect quality of sexual life positively. 相似文献The purpose of this study was to investigate the prevalence of obstructive sleep apnea (OSA) in patients with hemoptysis.
MethodsFiles of patients who had undergone bronchial arterial embolization due to hemoptysis between 1 December 2009 and 2015 were evaluated and interviews of patients were conducted until 1 June 2016. Pittsburgh Sleep Quality Index (PSQI), STOP and STOP-BANG surveys were administered. OSA risk was determined with Berlin Questionnaire.
ResultsStudy group consisted of 53 patients and 58 control subjects. Mean age was 46.94 ± 14.36 and 41.97 ± 12.92 in patient and control group, respectively. Of these patients, seven had re-embolization procedure because of recurrence of hemoptysis. High OSA risk was more common among patients with hemoptysis (24.5%, n = 13) than the control group (8.6%, n = 5) (p = 0.023). Percentage of high risk OSA patients with massive hemoptysis, nonmassive hemoptysis, and control subjects was 29.7% (n = 11), 12.5% (n = 2), and 8.6% (n = 5), respectively (p = 0.022). There were more high OSA risk subjects among patients with idiopathic hemoptysis 44.4% (four out of nine), while 20.5% (nine out of 53) patients with a known etiology had high risk (p = 0.127). The number of patients with high OSA risk was also higher in patients who required a second embolization procedure (four out of seven, 57.1%), while 19.6% of patients without need for re-embolization had high risk (p = 0.031).
ConclusionsOSA is found to be a risk factor for hemoptysis and also may provoke massive hemoptysis. It seems reasonable to consider OSA as an underlying condition in idiopathic hemoptysis. OSA may contribute to embolization failure.
相似文献